Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial

Hideki Ueno,Megumi Ishiguro,Eiji Nakatani,Toshiaki Ishikawa,Hiroyuki Uetake,Chu Matsuda,Yoshihiko Nakamoto,Masanori Kotake,Kiyotaka Kurachi,Tomohisa Egawa,Keigo Yasumasa,Kohei Murata,Osamu Ikawa,Seiichi Shinji,Kenta Murotani,Shigeyuki Matsui,Satoshi Teramukai,Naohiro Tomita,Kenichi Sugihara

Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial

2019

Hideki Ueno
Megumi Ishiguro
Eiji Nakatani
Toshiaki Ishikawa
Hiroyuki Uetake
Chu Matsuda
Yoshihiko Nakamoto
Masanori Kotake
Kiyotaka Kurachi
Tomohisa Egawa
Keigo Yasumasa
Kohei Murata
Osamu Ikawa
Seiichi Shinji
Kenta Murotani
Shigeyuki Matsui
Satoshi Teramukai
Naohiro Tomita
Kenichi Sugihara

PURPOSEThe International Union Against Cancer highlighted tumor budding as a tumor-related prognostic factor. International assessment criteria for tumor budding were recently defined by the 2016 I...

Keywords:

Tumor budding
Stage ii colon cancer
Pathology
Cancer
Internal medicine
Medicine
Oncology
prognostic factor
multicenter study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations